Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Beclometasone controlled-release - Chiesi

Drug Profile

Beclometasone controlled-release - Chiesi

Alternative Names: Beclomethasone controlled-release - Chiesi; Beclomethasone dipropionate controlled-release - Chiesi; CHF-1514; Clipper; EUR-1073

Latest Information Update: 15 Jun 2017

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Chiesi Farmaceutici
  • Developer Chiesi Farmaceutici; Eurand
  • Class Antiallergics; Antiasthmatics; Chlorinated steroids; Corticosteroids; Pregnadienetriols; Small molecules; Vascular disorder therapies
  • Mechanism of Action Immunosuppressants; Steroid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Ulcerative colitis
  • New Molecular Entity No

Highest Development Phases

  • Marketed Ulcerative colitis
  • Discontinued Inflammatory bowel diseases

Most Recent Events

  • 16 May 2017 Chiesi initiates enrolment in the BeCalCU phase III trial for Ulcerative colitis in Spain (EudraCT2017-000330-61)
  • 03 Feb 2014 Aptalis has been acquired by Forest Laboratories
  • 11 Feb 2011 Eurand has been acquired and merged into Axcan Pharma
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top